|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 6 |
| 1.1 List of Tables | 6 | 1 |
| 1.2 List of Figures | 7 | 1 |
| 2 Introduction | 8 | 1 |
| 2.1 What Is This Report About? | 8 | 1 |
| 3 Definitions of Markets Covered in This Report | 9 | 2 |
| 3.1 Drug delivery devices | 9 | 1 |
| 3.2 Inhalation Systems | 9 | 1 |
| 3.2.1 Metered Dose Inhaler | 9 | 1 |
| 3.2.2 Dry powder inhaler | 9 | 1 |
| 3.3 Infusion Systems | 9 | 1 |
| 3.3.1 Infusion pumps | 9 | 1 |
| 3.3.2 Syringe pumps | 9 | 1 |
| 3.3.3 Disposable Infusion sets | 10 | 1 |
| 4 Healthcare Sector Review | 11 | 3 |
| 4.1 Healthcare Expenditure | 11 | 3 |
| 5 Regulation System | 14 | 4 |
| 5.1 Device Classification | 14 | 1 |
| 5.2 Registration Process | 14 | 2 |
| 5.3 Labeling Requirements | 16 | 1 |
| 5.4 Import Documentation | 17 | 1 |
| 6 Pricing and Reimbursement | 18 | 1 |
| 7 Distribution Structure | 19 | 1 |
| 8 Drug Delivery Devices In Mexico | 20 | 8 |
| 8.1 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015 | 20 | 4 |
| 8.2 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015 | 24 | 3 |
| 8.3 Drug Delivery Devices, Mexico, Company Share (2007-2008) | 27 | 1 |
| 9 Infusion Systems In Mexico | 28 | 6 |
| 9.1 Infusion Systems Overall Revenue (2000-2015) | 28 | 2 |
| 9.2 Infusion Systems Overall Volume (2000-2015) | 30 | 1 |
| 9.3 Infusion Systems Average Price (2000-2015) | 31 | 1 |
| 9.4 Infusion Systems Distribution Share (2007-2008) | 32 | 1 |
| 9.5 Infusion Systems, Mexico, Company Share (2007-2008) | 33 | 1 |
| 10 Inhalation Systems In Mexico | 34 | 7 |
| 10.1 Inhalation Systems Overall Revenue (2000-2015) | 34 | 2 |
| 10.2 Inhalation Systems Overall Volume (2000-2015) | 36 | 2 |
| 10.3 Inhalation Systems Average Price (2000-2015) | 38 | 1 |
| 10.4 Inhalation Systems Distribution Share (2007-2008) | 39 | 1 |
| 10.5 Inhalation Systems, Mexico, Company Share (2007-2008) | 40 | 1 |
| 11 Overview of Key Companies in Mexico Drug Delivery Devices Market | 41 | 12 |
| 11.1 AstraZeneca PLC | 41 | 1 |
| 11.1.1 Company Overview | 41 | 1 |
| 11.2 Boehringer Ingelheim GmbH | 41 | 1 |
| 11.2.1 Company Overview | 41 | 1 |
| 11.3 Baxter International Inc. | 42 | 1 |
| 11.3.1 Company Overview | 42 | 1 |
| 11.4.1 Company Overview | 42 | 1 |
| 11.5 Terumo Corporation | 43 | 1 |
| 11.5.1 Company Overview | 43 | 1 |
| 11.5.2 Terumo Corporation Pipeline Products | 43 | 1 |
| 11.5.2.1 Terumo Corporation Pipeline Products By Equipment Type | 43 | 1 |
| 11.5.2.2 Terumo Corporation Pipeline Products By Development Stage | 43 | 1 |
| 11.5.2.3 Terumo Corporation Pipeline Products By Therapy Area | 44 | 1 |
| 11.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials | 44 | 1 |
| 11.5.2.5 Terumo Corporation Pipeline Products By News Summary | 45 | 1 |
| 11.6 Cardinal Health, Inc. | 46 | 1 |
| 11.6.1 Company Overview | 46 | 1 |
| 11.7 GlaxoSmithKline plc | 47 | 1 |
| 11.7.1 Company Overview | 47 | 1 |
| 11.8 B. Braun Melsungen AG | 48 | 1 |
| 11.8.1 Company Overview | 48 | 1 |
| 11.9 Smiths Medical | 48 | 1 |
| 11.9.1 Company Overview | 48 | 1 |
| 11.10 Fresenius Kabi AG | 49 | 1 |
| 11.10.1 Company Overview | 49 | 1 |
| 11.11 Consort Medical plc | 50 | 1 |
| 11.11.1 Company Overview | 50 | 1 |
| 11.11.2 Consort Medical plc Pipeline Products | 50 | 1 |
| 11.11.2.1 Bespak plc Pipeline Products By Equipment Type | 50 | 1 |
| 11.11.2.2 Bespak plc Pipeline Products By Development Stage | 50 | 1 |
| 11.11.2.3 Bespak plc Pipeline Products By Therapy Area | 51 | 1 |
| 11.12 Hospira, Inc. | 52 | 1 |
| 12 Appendix | 53 | 5 |
| 12.1 Global Markets Direct Research Methodology | 53 | 1 |
| 12.2 Secondary Research | 54 | 1 |
| 12.3 Primary Research | 54 | 1 |
| 12.4 Models | 55 | 1 |
| 12.5 Forecasts | 55 | 1 |
| 12.6 Expert Panel Validation | 55 | 1 |
| 12.7 Currency Conversion | 56 | 1 |
| 12.8 Contact Us | 57 | 1 |
| 12.9 Disclaimer | 57 | 1 |